Voice problems from testosterone supplementation may be more permanent and widespread than many women realize. While testosterone therapy has gained popularity among cisgender women seeking relief from low libido, fatigue, and menopausal symptoms, the vocal consequences receive little attention despite their potential irreversibility.
Nebraska Medicine laryngologists documented voice disorders in 34 women who developed dysphonia after testosterone treatment. Two-thirds developed muscle tension dysphonia, while nearly 65% showed vocal fold swelling on examination. Patients reported moderate voice handicap scores averaging 20 out of 40 points, indicating significant functional impairment. The women had used various testosterone formulations including topical gels, pellets, injections, oral preparations, and compounded creams.
Of the 19 women who completed voice therapy, only six fully restored their vocal function. Twelve achieved partial improvement, while one showed no progress despite treatment. The remaining patients were lost to follow-up, suggesting the difficulty many face in addressing these complications.
This research highlights a concerning gap in informed consent for off-label testosterone use in women. Unlike transgender men who typically receive counseling about voice changes as an expected outcome, cisgender women pursuing testosterone for wellness benefits may be unprepared for permanent vocal masculinization. The vocal cords contain androgen receptors that respond irreversibly to testosterone exposure, potentially deepening pitch and altering voice quality permanently. Given testosterone's growing use for female hormone optimization, healthcare providers should explicitly discuss voice risks before prescribing, and patients should weigh vocal changes against potential benefits.